The Claim

In adults aged 60–65 without cardiovascular disease but at intermediate risk, daily combination therapy with rosuvastatin (10 mg), candesartan (16 mg), and hydrochlorothiazide (12.5 mg) for a median of 5.6 years increases the risk of muscle weakness by 0.9 percentage points and dizziness by 2.2 percentage points compared to dual placebo, without increasing serious adverse events or discontinuation rates.

Source: Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
82score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

In adults aged 60–65 at intermediate risk for cardiovascular disease but without existing disease, taking a daily combination of rosuvastatin, candesartan, and hydrochlorothiazide for about 5.6 years increases the occurrence of muscle weakness by 0.9 percentage points and dizziness by 2.2 percentage points compared to taking two placebo pills, with no increase in serious side effects or treatment discontinuation.

See the scientific wording

In adults aged 60–65 without cardiovascular disease but at intermediate risk, daily combination therapy with rosuvastatin (10 mg), candesartan (16 mg), and hydrochlorothiazide (12.5 mg) for a median of 5.6 years increases the risk of muscle weakness by 0.9 percentage points and dizziness by 2.2 percentage points compared to dual placebo, without increasing serious adverse events or discontinuation rates.

Why this might work

The drugs reduce sodium and fluid in the body, which changes the balance of minerals like potassium and magnesium in muscle cells. This disrupts how muscle cells produce energy, making them weaker and less able to contract properly. At the same time, the brain receives less stable signals from the inner ear due to fluid shifts, causing dizziness.

Supported mechanismbased on 1 study

What the research says

1 study
  1. Study: Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

    The study found that taking this three-in-one pill for about six years didn’t make people more likely to quit the medicine or have serious health problems, even though some might feel a bit more dizzy or weak — which matches the claim. It also kept hearts healthier.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.